Skip to main content
. Author manuscript; available in PMC: 2019 Jan 1.
Published in final edited form as: Curr Opin Clin Nutr Metab Care. 2018 Jan;21(1):30–36. doi: 10.1097/MCO.0000000000000426

Figure 1.

Figure 1

A number of metabolic and molecular perturbations that contributes to ammonia induced dysregulated proteostasis and the potential treatments targeting these abnormalities can reverse sarcopenia in liver disease.